Study on the Level of Fetuin-A and the Relationship between Fetuin-A and Insulin Resistance in Patients with Chronic Hepatitis C
Department of Laboratory Medicine,the First Affiliated Hospital of Wenzhou Medical University,Wenzhou 325000,China
*Corresponding author:WANG Yumin,Associate chief technician;E-mail:wym0577@163.com
WU Lingling,ZHENG Xiaoyong,HU Lijuan, et al. Study on the Level of Fetuin-A and the Relationship between Fetuin-A and Insulin Resistance in Patients with Chronic Hepatitis C [J]. Chinese General Practice, 2019, 22(9): 1039-1042. DOI: 10.12114/j.issn.1007-9572.2018.00.336.
吴玲玲,郑晓勇,胡丽娟等. 慢性丙型肝炎患者胎球蛋白A变化及其与胰岛素抵抗关系研究[J]. 中国全科医学, 2019, 22(9): 1039-1042. DOI: 10.12114/j.issn.1007-9572.2018.00.336.
[1]PAZHANIVEL M,JAYANTHI V.Diabetes mellitus and cirrhosis liver[J].Minerva Gastroenterol Dietol,2010,56(1):7-11.
[2]QIU N C,ZHANG Q,SONG X,et al.Impact of the hepatic branch of the vagus and Roux-en-Y gastric bypass on the hypoglycemic effect and glucagon-like petide-1 in rats with type 2 diabetes mellitus[J].J Surg Res,2014,191(1):123-129.DOI:10.1016/j.jss.2014.03.062.
[3]NAING C,MAK J W,AHMED S I,et al.Relationship between hepatitis C virus infection and type 2 diabetes mellitus:meta-analysis[J].World J Gastroenterol,2012,18(14):1642-1651.DOI:10.3748/wjg.v18.i14.1642.
[4]MOUCARI R,ASSELAH T,CAZALS-HATEM D,et al.Insulin resistance in chronic hepatitis C:association with genotypes 1 and 4,serum HCV RNA level,and liver fibrosis[J].Gastroenterology,2008,134(2):416-423.DOI:10.1053/j.gastro.2007.11.010.
[5]TRPKOVIC A,STOKIC E,RADAK D,et al.Chronic hepatitis C,insulin resistance and vascular disease[J].Curr Pharm Des,2010,16(34):3823-3829.
[6]FALLAHI P,FERRARI S M,COLACI M,et al.Hepatitis C virus infection and type 2 diabetes[J].Clin Ter,2013,164(5):e393-404.
[7]GARCIA-COMPEáN D,GONZALEZ-GONZALEZ J A,LAVALLE-GONZALEZ F J,et al.Current concepts in diabetes mellitus and chronic liver disease:clinical outcomes,hepatitis C virus association,and therapy[J].Dig Dis Sci,2016,61(2):371-380.DOI:10.1007/s10620-015-3907-2.
[8]IOVANESCU V F,STREBA C T,IONESCU M,et al.Diabetes mellitus and renal involvement in chronic viral liver disease[J].J Med Life,2015,8(4):483-487.
[9]SPRADLING P R,SIMONS B,NARAYANAN M,et al.Incidence of diabetes mellitus in a population-based cohort of persons with chronic hepatitis B virus infection[J].J Viral Hepat,2013,20(7):510-513.DOI:10.1111/jvh.12071.
[10]NAING C,MAK J W,AHMED S I,et al.Relationship between hepatitis C virus infection and type 2 diabetes mellitus:metaanalysis[J].World J Gastroenterol,2012,18(14):1642-1651.DOI:10.3748/ wjg.v18.i14.1642.
[11]ALI S A,NASSIF W M,ABDELAZIZ D H.Alterations in serum levels of fetuin A and selenoprotein P in chronic hepatitis C patients with concomitant type 2 diabetes:a case-control study[J].Clin Res Hepatol Gastroenterol,2016,40(4):465-470.DOI:10.1016/j.clinre.2015.12.003.
[12]MEHTA S H,BRANCATI F E,STRATHDEE S A,et al.Hepatitis C virus infection and incident type 2 diabetes[J].Hepatolagy,2003,38(1):50-56.DOI:10.1053/jhep.2003.50291.
[13]LECUBE A,HEMANDEZ C,GENESCA J,et al.High prevalence of use abnormalities in patients with hepatitis C virus infection:a multivariate analysis considering the liver injury[J].Diabetes Care,2004,27(5):1171-1175.
[14]KAWAGUCHI T,YOSHIDA T,HARADA M,et al.Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3[J].Am J Pathol,2004,165(5):1499-1508.
[15]HICKMAN T J,POWELL E E,PRINS J B,et al.In overweight patients with chronic hepatitis C,circulating insulin is associated with hepatic fibrosis:implications for therapy[J].J Hepatol,2003,39(6):1042-1048.
[16]李光伟.胰岛素抵抗评估及其临床应用[J].中华老年多器官疾病杂志,2004,3(1):11-12.
[17]IKEDA Y,SUEHIRO T,NAKAMURA T,et al.Clinical significance of the insulin resistance index as assessed by homeostasis model assessment[J].Endocr J,2001,48(1):81-86.
[18]GOUSTIN A S,ABOU-SAMRA A B.The "thrifty" gene encoding Ahsg/Fetuin-A meets the insulin receptor:insights into the mechanism of insulin resistance[J].Cell Signal,2011,23(6):980-990.DOI:10.1016/j.cellsig.2010.11.003.
[19]PESSIN J E,SALTIEL A R.Signaling pathways in insulin action:molecular targets of insulin resistance[J].J Clin Invest,2000,106(2):165-169.DOI:10.1172/JCI10582.
[20]GOUSTIN A S,DERAR N,ABOU-SAMRA A B.Ahsg-fetuin blocks the metabolic arm of insulin action through its interaction with the 95-kD β-subunit of the insulin receptor[J].Cell Signal,2013,25(4):981-988.DOI:10.1016/j.cellsig.2012.12.011.
[21]陈婷,靳彦文,瞿秀华,等.胎球蛋白A的纯化及其对3T3-L1脂肪细胞胰岛素通路的抑制作用[J].解放军医学杂志,2010,35(7):819-822.
CHEN T,JIN Y W,QU X H,et al.Purification of AHSG and its inhibition effect on insulin pathway of 3T3-L1 adipocyte[J].Med J Chin PLA,2010,35(7):819-822.
[22]张春梅,陈婷,李平,等.AHSG对胰岛素刺激下的HL-7702细胞中FAS、SREBP-1基因表达的影响[J].军事医学,2012,36(3):182-185,195.DOI:10.3969/j.issn.1674-9960.2012.03.005.
ZHANG C M,CHEN T,LI P,et al.AHSG impact on expression of FAS and SREBP-1 genes of HL-7702 cells under insulin treatment[J].Military Medical Sciences,2012,36(3):182-185,195.DOI:10.3969/j.issn.1674-9960.2012.03.005.